PRECISION MEDICINE AND MONOGENIC DIABETES: ADVANCES, CHALLENGES, AND FUTURE PERSPECTIVES (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorSOUZA, KAMILA MAGALHÃES-
Autor(es): dc.contributor.authorBERNABÉ, ANA CLARA PESSOA-
Autor(es): dc.contributor.authorVIEIRA, CAROLINE GONÇALVES-
Autor(es): dc.contributor.authorPEREIRA, MARIANA DE OLIVEIRA AMARO-
Autor(es): dc.contributor.authorPAIVA, GÉSSICA CAMPOS-
Autor(es): dc.contributor.authorTIOSSO, JÉSSICA VILLELA-
Autor(es): dc.contributor.authorANTES, RAFAELLA BREMM-
Autor(es): dc.contributor.authorDUARTE, LAURA BRAGA BARÃO-
Autor(es): dc.contributor.authorMICHELON, TAÍS BRUNA-
Autor(es): dc.contributor.authorWAIHRICH, GABRIELLY PEREIRA-
Autor(es): dc.contributor.authorFERRARI, ISABELLE LAYS DE CASTRO-
Autor(es): dc.contributor.authorSACRAMENTO, NEIDEJANY DE ASSUNÇÃO DO-
Data de aceite: dc.date.accessioned2023-07-12T20:16:25Z-
Data de disponibilização: dc.date.available2023-07-12T20:16:25Z-
Data de envio: dc.date.issued2023-06-30-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/733937-
Resumo: dc.description.abstractObjective: Address recent advances in precision medicine in the diagnosis and treatment of monogenic diabetes, including MODY, neonatal diabetes and rare forms. Method: The report was prepared between April and May 2023, following the PVO strategy. A search was performed in the PubMed database, using descriptors such as "Monogenic Diabetes", "MODY", "Diabetes Maturity Onset of the Young", "Neonatal Diabetes" and "Precision Medicine". Sixteen articles selected after inclusion and exclusion criteria were analyzed, of the 88 found. Results: Precision medicine is revolutionizing the treatment of single-gene diabetes, identifying specific mutations and providing more effective therapies. Lifestyle and dietary modifications are recommended for HNF1A-MODY, and the use of sulfonylureas may be considered. In the case of NDM, it is possible to transition from insulin to sulfonylureas. In insulin-resistant diabetes, the use of insulin-sensitizing agents is preferred. Early diagnosis and insulin treatment are key for LADA. Precision medicine improves the quality of life for patients with monogenic diabetes. Final considerations: Precision medicine has brought significant advances in the diagnosis and treatment of monogenic diabetes, providing more effective therapies and better quality of life for affected patients. These advances represent an important step towards personalized medicine for single-gene diabetes.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectMonogenic Diabetespt_BR
Título: dc.titlePRECISION MEDICINE AND MONOGENIC DIABETES: ADVANCES, CHALLENGES, AND FUTURE PERSPECTIVES (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais